Vistin Pharma ASA (FRA:VP4)

Germany flag Germany · Delayed Price · Currency is EUR
1.660
+0.005 (0.30%)
Last updated: Dec 4, 2025, 9:11 AM CET
-25.56%
Market Cap 74.59M
Revenue (ttm) 38.85M
Net Income (ttm) 6.66M
Shares Out n/a
EPS (ttm) 0.15
PE Ratio 11.20
Forward PE n/a
Dividend 0.15 (8.73%)
Ex-Dividend Date Jun 4, 2025
Volume n/a
Average Volume 3,653
Open 1.660
Previous Close 1.655
Day's Range 1.660 - 1.660
52-Week Range 1.660 - 2.100
Beta n/a
RSI 37.08
Earnings Date Apr 24, 2026

About Vistin Pharma ASA

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is based in Oslo, Norway. [Read more]

Industry Medicinal Chemicals and Botanical Products
Founded 1969
Employees 75
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol VP4
Full Company Profile

Financial Performance

In 2024, Vistin Pharma ASA's revenue was 429.50 million, a decrease of -2.01% compared to the previous year's 438.33 million. Earnings were 62.75 million, an increase of 37.62%.

Financial numbers in NOK Financial Statements

News

There is no news available yet.